Overview
- 43 inspections across 42 sites are on record.
- 79 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2018-04-20.
At a glance
Inspections
43
Sites
42
Observations
79
Career since
Jan 2015
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Aphena Pharma Solutions - Maryland, LLC | 20 Apr 2018 | Human Drugs | On file |
| Nutravail, LLC. | 20 Mar 2018 | Human Drugs | On file |
| United Therapeutics Corporation | 16 Feb 2018 | Human Drugs | |
| Cape Drugs | 22 Jan 2018 | Human Drugs | View 483 → |
| QuVa Pharma, Inc. | 30 Nov 2017 | Human Drugs | View 483 → |
Sites inspected
Aphena Pharma Solutions - Maryland, LLCEaston, United States1 insp.
Nutravail, LLC.Chantilly, United States1 insp.
United Therapeutics CorporationBeltsville, United States1 insp.
Cape DrugsAnnapolis, United States1 insp.
QuVa Pharma, Inc.Bloomsbury, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Tonia F Bernard10 shared
Gianine E Tompkins3 shared
Niketa Patel3 shared
Emmanuel J Ramos2 shared
Melissa T Roy2 shared
Guerlain Ulysse2 shared
Liatte Krueger2 shared
Michael R Klapal2 shared
Jogy George2 shared
Neda Hamandi1 shared
Full investigator report
Get the verbatim findings behind Zakaria I Ganiyu's 79 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site